Phospho-c-Raf (Ser338) Antibody

About the Target

The Raf family of kinases, comprising A-Raf, B-Raf, and c-Raf (Raf-1), are key serine/threonine protein kinases that act as downstream effectors of Ras, playing essential roles in regulating cell proliferation, survival, and tumorigenesis. c-Raf contains a core kinase domain responsible for phosphorylating downstream targets like MEK, and multiple phosphorylation sites that regulate its activity. Phosphorylation at Ser338 is crucial for c-Raf activation; it can occur in response to mitogenic signals or independently of Ras via Cdc42/Rac/Pak activation following microtubule depolymerization. Depending on the literature source, C-RAF may also be discussed as Phospho-c-Raf (Ser338).

Reported cellular context includes cell membrane, cytoplasm, membrane, and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following C-RAF across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

C-RAF is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, cytoplasm, and membrane across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for C-RAF. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in C-RAF reflect biology rather than handling. When interpreting C-RAF, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep C-RAF trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.